Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Cell Oncol (Dordr). 2022 Dec;45(6):1237-1251. doi: 10.1007/s13402-022-00713-5. Epub 2022 Sep 23.
Cell Oncol (Dordr). 2022.
PMID: 36149602
Free PMC article.
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma.
Sciandra M, De Feo A, Parra A, Landuzzi L, Lollini PL, Manara MC, Mattia G, Pontecorvi G, Baricordi C, Guerzoni C, Bazzocchi A, Longhi A, Scotlandi K.
Sciandra M, et al.
J Cell Commun Signal. 2020 Sep;14(3):335-347. doi: 10.1007/s12079-020-00567-2. Epub 2020 Jun 5.
J Cell Commun Signal. 2020.
PMID: 32504411
Free PMC article.
Item in Clipboard
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Pasello M, Giudice AM, Cristalli C, Manara MC, Mancarella C, Parra A, Serra M, Magagnoli G, Cidre-Aranaz F, Grünewald TGP, Bini C, Lollini PL, Longhi A, Donati DM, Scotlandi K.
Pasello M, et al.
Cell Oncol (Dordr). 2022 Dec;45(6):1253. doi: 10.1007/s13402-022-00735-z.
Cell Oncol (Dordr). 2022.
PMID: 36352194
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite